Harnessing immunogenic cell death (ICD)—an immunostimulatory form of cancer cell death in the tumor microenvironment—to help activate a patient’s immunity and trigger a tumor-specific immune ...

The team, led by Martin McIntosh, Ph.D., head of the Computational Biology Program at Fred Hutch, is using high-throughput technology and emerging public data resources to help identify hundreds of ...

EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a ...